We constructed job-exposure profiles and assessed quality of health care in 39 of 47 current and former workers from a nuclear installation in the Negev whose files were referred to us for assessment of a possible work-related aspect of their tumors. The workers, all male except one, began employment at various times from the reactor construction and were engaged in different tasks in laboratory research, construction, maintenance, and service. Of those workers still living the average age was 57.9 years, with a range from 42 to 77 years of age. The average age at the time of death for the deceased workers was 57.3 years, with a range from 41 to 69 years of age. Information on past exposures to radiation and chemical agents came from employee records, dosimetry, and interviews. Personal monitoring (urine assays) in 29 workers indicated the presence of various radionuclides, with higher levels found in persons with work histories in laboratory/research and development and technical/inspector job categories compared to those in administrative/service job categories. Among the 39 workers, latency between onset of exposure and first appearance of illness from tumor was 24.2 years, with a range of 5 to 34 years. Tumor distribution for these workers was as follows: hematolymphatic (n = 11 workers), gastrointestinal (n = 9), breast (n = 1 [male]), brain (n = 1), renal-urogenital (n = 8), skin (n = 1), and pulmonary (n = 8 [5 known smokers]). For all tumors except those of the respiratory tract, the first diagnosis was made more frequently in those patients under the age of 55. Observed/expected comparisons for tumor proportional incidence showed excess fractions of blood tumors in persons < 55 and > 55 years of age. Ratios were greater than unity for blood, breast (n= 1), gastrointestinal, and urogenital tumors in patients < 55 years of age and pulmonary tumors in persons > 55 years of age. The odds ratio for smoking history in patients with lung tumors compared to those with other tumors was 4.8. Nonmalignant conditions appeared at relatively younger ages. After the exposure episodes two children with major congenital anomalies were born to wives of the workers; one anomaly was fatal. Not all patients were first diagnosed for cancer following referral from the plant medical service, and delays between warning signs and symptoms and medical evaluation occurred in some. Although we lacked data on cancer incidence and population at risk, our findings suggest that earlier official assessments of risk should be reconsidered. There is a need for population-based monitoring of risk to nuclear industry workers, external quality control of their medical surveillance and care, and improvements in information delivery.
Introduction
Forty-seven Israeli nuclear industry workers 20 were still alive, and 3 workers could not were referred to us for assessment of a pos-be traced. sible work-related aspect of their illnesses.
Our objectives were to examine the Of these 47 workers 24 had already died, exposure histories of these workers in relation to their tumor types, and to evaluate the quality of their environmental and personal protection and the health care they received. We were guided in this preliminary examination by past epidemiologic studies on the excess risks of individuals exposed to ionizing radiation. Among the diagnoses explored in these studies were leukemia (1) (2) (3) (4) (5) ; lymphoma (5, 6) ; multiple myeloma (3, 7) ; solid cancers (8) ; bone marrow cancer (7); and cancer of the stomach (6, 9) , pancreas (7), lung (6, 7) , prostate (6) , gastrointestinal tract (5, 6) , and brain (5) .
An unpublished epidemiologic report by the Ministry of Environmental Quality indicated that there was no evidence of an increased risk for all cancers or specific tumors among nuclear industry workers at the same plant (10) . In Israel the worker exposure standard is 5000 mrem or 50 mSv (whole-body exposure) per year, as recommended by the International Commission on Radiological Protection in 1976 (11) .
Methods
Most of the workers were referred to us through their trade union representatives. All of the workers had resided in the northern Negev in Israel. and their work involved nuclear reprocessing and research and development (R&D) . All of the 47 patients studied except 1 had been diagnosed at least once with cancer between 1965 and 1995 Nineteen patients were diagnosed before 1991 and 17 were diagnosed after 1991. The date of diagnosis was unknown for three workers; 7 had incomplete data. We have no precise information on what fraction these workers represented of all persons with or without tumors from this worksite.
We abstracted information from government worksite medical and employment records of the 47 workers. Interviews of the patients who were still alive substantiated and augmented this database. We have no way of determining, in absolute terms, the degree of reliability and completeness of the data recorded in these records, although files of all or nearly all individual patients clearly contained data gaps concerning exposure records and findings from periodic medical examinations.
We collected data on age, sex, onset of employment, job dates, types ofjobs, work tasks, work conditions, personal work practices, and types of agents to which Environmental Health Perspectives * Vol 105, Supplement 6 * December 1997 m workers were exposed in each job. Report We found suggestions that spatial zoning of work areas was sometimes used as a substitute for rigid enclosure and separation of hazardous processes.
The worksite reportedly had provided most of the workers with recommended standard means of personal protection i.e., clothing, showers, and separate eating areas, although exceptions were noted. Several workers reported that in the past, eating and drinking while working in the lab was not prohibited by the supervisors. Many workers reported that they occasionally did not shower at the end of the work day to avoid missing the company bus ride home. They also reported not having their clothing cleaned or replaced as required.
Environmental and Personal Monitoring
Reportedly, the site was equipped with the proper Geiger-Muller counters (and possibly scintillation crystal counters and semiconductor counters as well), pocket ionization chambers (PICs), and thermoluminescence detectors. All workers reported at least one of the above environmental or personal detectors was present in each of the working environments at all times, although the usual custom was to pin the PICs on white laboratory coats that frequently were not worn and were left in clothes lockers.
Radionuclides: Biological Monitoring
Results from urine assays for radionuclides were collected from 29 available medical files and analyzed. Radionuclides 
Chronic Illnesses and Conditions Other than Cancer
We had access to the medical files of 26 of the 39 workers (67%) and most records were incomplete. Fifteen patients (five smokers) had cardiocirculatory problems and four (one smoker) had chronic chest conditions. Complaints of dizziness, nausea, headaches, and fatigue during working hours were also reported (Table 6 ). An examination of Table 6 suggests that the onset of some of these conditions occurred at fairly young ages, i.e., < 55 years of age.
One patient, a chemical technician with breast cancer, had exposures to solvents and ionizing radiation, reported high-exposure mishaps, and was diagnosed at 45 years of age with proliferative glomerulonephritis. Another patient, a lab manager later diagnosed with cancer of the rectum, had exposures to solvents and suffered from chronic thrombocytopenia from age 27 onward, as well as unspecified lung disease. After a splenectomy the worker continued to have thrombocytopenia and later suffered from obesity, diabetes, and retinal detachments. A patient with cancer of the prostate was a heavy smoker who developed hypertension at 35 years of age following massive exposure to lead from smelting and later developed chronic obstructive lung disease.
One male worker reported that within a year and a half after an episode of acute radiation illness from a reported mishap, he fathered a male child who suffers from a clubbed foot, asthma, problems with growth hormones, atopic dermatitis, and celiac disorder. Another male worker reported that his child died at 6 years of age due to congenital heart disease.
Medical Examinations and Communicaton ofInformation
As a medical routine the workers were to to undergo 6-month periodic examinations and an annual whole-body checkup. Yet there were large fluctuations in the frequency of medical exams (1 to 2/year) and large documentation gaps for a majority of the person-years of employment follow-up. On average, for each of the 29 medical records, information gaps totaled an average of 9.3 years/patient, which usually meant two examinations per year. Patients reported that they received interpretations of the results of their exams without the raw numbers. The overall impression was that a systematic approach linking outcomes to information from job exposure matrices and including data on atypical episodes was not fully developed and in the case of exposures to chemicals was nonexistent.
Thirty-one of the 39 patients (80%) had their cancers first diagnosed by the regional referral hospital. Ten of 17 patients who developed cancer while employed at the site were diagnosed following a referral by the plant physician, but in no case was the worker told of the diagnosis. For Tumor onset was only recently diagnosed in many of the individuals in this series. This suggests that the previously cited government investigation (10) that reported unremarkable or lower than expected risks for all tumors and specific organ sites for workers at this industrial site up to 1991 must be updated given the importance of latency for an occupational population and the need for risk assessment in specified exposure subgroups using the standard methods of cohort studies. Given the high selection standards for work in the nuclear industry these risks must be assessed in light of the influence of the healthy worker effect for this cohort.
All carcinogens including ionizing radiation have noncarcinogenic effects as well, usually from higher exposures. These effects appear earlier and are more widespread. The occurrence of these outcomes in persons with exposures to ionizing radiation could be regarded as sentinel markers for such exposures and therefore is of interest. Our findings list those nonmalignant outcomes that in some cases are associated with hazardous exposures and in others are from smoking or other circumstances. However, no statement can be made about risk.
In conclusion, because our findings are based on a patient series we cannot draw any inferences as to whether there were excess risks for cancer or other outcomes at this nuclear installation. However, the findings do suggest the need for testing the hypothesis that there were possible excess cancer risks for certain organ sites, notably in persons with past work in the technical/inspector and laboratory/R&D job categories. Without complete data on cancer incidence and data on population at risk it cannot be determined whether these risks exceed unity.
